DVA:NYE-DaVita HealthCare Partners Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 160.33

Change

0.00 (0.00)%

Market Cap

USD 11.58B

Volume

1.16M

Analyst Target

USD 97.80
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 89.71B
THC Tenet Healthcare Corporation

N/A

USD 15.44B
UHS Universal Health Services Inc

N/A

USD 13.69B
EHC Encompass Health Corp

N/A

USD 10.27B
CHE Chemed Corp

N/A

USD 7.97B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 2.08B
BKD Brookdale Senior Living Inc

N/A

USD 1.04B
AMN AMN Healthcare Services Inc

N/A

USD 0.90B

ETFs Containing DVA

SANE 4.09 % 0.00 %

N/A

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.78 % 0.00 %

N/A

N/A
IBHJ 1.56 % 0.00 %

N/A

N/A
JPLG:LSE JPM Global Equity Multi-F.. 0.34 % 0.00 %

N/A

N/A
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 0.01B
FLAG 0.00 % 1.52 %

N/A

N/A
PHB Invesco Fundamental High .. 0.00 % 0.50 %

N/A

N/A
BACK:LSE 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 53.05% 87% B+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.05% 87% B+ 93% A
Trailing 12 Months  
Capital Gain 66.73% 87% B+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.73% 87% B+ 92% A
Trailing 5 Years  
Capital Gain 125.69% 89% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 125.69% 89% A- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.34% 57% F 74% C
Dividend Return 14.34% 57% F 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 34.05% 65% D 30% F
Risk Adjusted Return 42.11% 70% C- 59% D-
Market Capitalization 11.58B 86% B+ 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector